is saxenda a glp 1 drug Article » ProAct FDA Approves First Generic GLP-1
Description
Wuestenberghs F, Juge M, Melchior C, Desprez C, Leroi AM, Gourcerol G

doi: 10.1210/clinem/dgad361

Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, et al
Your appetite suppression has stabilized and you are no longer seeing progressive changes at the current level

Emmerich SD, Fryar CD, Stierman B, Ogden CL, Obesity
doi: 10.1007/s13300-019-00735-7
